Dipna Pharmachem Limited (BOM:543594)
India · Delayed Price · Currency is INR 5.50
-0.40 (-6.78%)
At close: Aug 25, 2026
Dipna Pharmachem Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 145 | 211 | 344 | 227 | 150 | - | |
Market Cap Growth | -69.86% | -38.68% | 51.80% | 50.78% | - | - |
Enterprise Value | 265 | 342 | 514 | 406 | 179 | - |
Last Close Price | 5.50 | 8.02 | 14.30 | 9.42 | 10.31 | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 5.50 | 8.01 | 35.30 | 20.87 | 16.47 | - |
PS Ratio | 0.11 | 0.16 | 0.28 | 0.14 | 0.15 | - |
PB Ratio | 0.23 | 0.34 | 0.89 | 0.60 | 0.62 | - |
P/TBV Ratio | 0.23 | 0.34 | 0.89 | 0.60 | 0.62 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.21 | 0.27 | 0.41 | 0.25 | 0.18 | - |
EV/EBITDA Ratio | 5.30 | 6.84 | 13.76 | 11.78 | 7.60 | - |
EV/EBIT Ratio | 5.31 | 6.86 | 13.80 | 11.84 | 7.64 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.21 | 0.21 | 0.45 | 0.52 | 0.65 | 5.86 |
Debt / EBITDA Ratio | 2.64 | 2.64 | 4.61 | 5.65 | 6.76 | 4.68 |
Debt / FCF Ratio | - | - | - | - | - | 3.64 |
Net Debt / Equity Ratio | 0.19 | 0.19 | 0.42 | 0.12 | 0.41 | 5.74 |
Net Debt / EBITDA Ratio | 2.40 | 2.40 | 4.31 | 1.32 | 4.24 | 4.59 |
Net Debt / FCF Ratio | -0.65 | -0.65 | -1.75 | -0.84 | -0.47 | 3.57 |
Asset Turnover | 0.76 | 0.76 | 0.94 | 1.56 | 1.76 | 2.38 |
Inventory Turnover | 3.08 | 3.08 | 3.51 | 5.61 | 7.57 | 10.17 |
Quick Ratio | 0.37 | 0.37 | 0.56 | 0.55 | 0.82 | 0.95 |
Current Ratio | 1.16 | 1.16 | 1.56 | 1.60 | 1.84 | 1.26 |
Return on Equity (ROE) | 5.22% | 5.22% | 2.56% | 3.51% | 6.99% | 101.02% |
Return on Assets (ROA) | 1.84% | 1.84% | 1.76% | 2.04% | 2.57% | 4.44% |
Return on Invested Capital (ROIC) | 4.98% | 5.74% | 5.29% | 6.86% | 6.71% | 13.15% |
Return on Capital Employed (ROCE) | 6.90% | 6.90% | 7.90% | 6.80% | 6.60% | 28.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 18.20% | 12.48% | 2.83% | 4.79% | 6.07% | - |
FCF Yield | -127.00% | -87.09% | -26.80% | -23.98% | -139.70% | - |
Buyback Yield / Dilution | -10.78% | -10.78% | -97.02% | -0.50% | -7042.07% | - |